vs
Side-by-side financial comparison of FIRST FINANCIAL CORP (THFF) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
FIRST FINANCIAL CORP is the larger business by last-quarter revenue ($70.5M vs $57.2M, roughly 1.2× Vanda Pharmaceuticals Inc.). FIRST FINANCIAL CORP runs the higher net margin — 30.4% vs -246.8%, a 277.2% gap on every dollar of revenue. On growth, FIRST FINANCIAL CORP posted the faster year-over-year revenue change (14.1% vs 7.6%). FIRST FINANCIAL CORP produced more free cash flow last quarter ($86.4M vs $-29.5M). Over the past eight quarters, FIRST FINANCIAL CORP's revenue compounded faster (20.8% CAGR vs 9.8%).
First American Financial Corporation is an American financial services company which provides title insurance and settlement services to the real estate and mortgage industries.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
THFF vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.5M | $57.2M |
| Net Profit | $21.5M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | 37.4% | -70.5% |
| Net Margin | 30.4% | -246.8% |
| Revenue YoY | 14.1% | 7.6% |
| Net Profit YoY | 32.1% | -2774.3% |
| EPS (diluted) | $1.81 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.5M | $57.2M | ||
| Q3 25 | $65.8M | $56.3M | ||
| Q2 25 | $63.1M | $52.6M | ||
| Q1 25 | $62.5M | $50.0M | ||
| Q4 24 | $61.8M | $53.2M | ||
| Q3 24 | $58.4M | $47.7M | ||
| Q2 24 | $49.2M | $50.5M | ||
| Q1 24 | $48.4M | $47.5M |
| Q4 25 | $21.5M | $-141.2M | ||
| Q3 25 | $20.8M | $-22.6M | ||
| Q2 25 | $18.6M | $-27.2M | ||
| Q1 25 | $18.4M | $-29.5M | ||
| Q4 24 | $16.2M | $-4.9M | ||
| Q3 24 | $8.7M | $-5.3M | ||
| Q2 24 | $11.4M | $-4.5M | ||
| Q1 24 | $10.9M | $-4.1M |
| Q4 25 | 37.4% | -70.5% | ||
| Q3 25 | 39.2% | -55.6% | ||
| Q2 25 | 36.2% | -73.2% | ||
| Q1 25 | 38.1% | -82.0% | ||
| Q4 24 | 32.4% | -19.3% | ||
| Q3 24 | 17.9% | -23.1% | ||
| Q2 24 | 27.6% | -20.1% | ||
| Q1 24 | 27.2% | -19.5% |
| Q4 25 | 30.4% | -246.8% | ||
| Q3 25 | 31.6% | -40.1% | ||
| Q2 25 | 29.5% | -51.7% | ||
| Q1 25 | 29.5% | -58.9% | ||
| Q4 24 | 26.3% | -9.2% | ||
| Q3 24 | 15.0% | -11.2% | ||
| Q2 24 | 23.1% | -9.0% | ||
| Q1 24 | 22.6% | -8.7% |
| Q4 25 | $1.81 | $-2.40 | ||
| Q3 25 | $1.75 | $-0.38 | ||
| Q2 25 | $1.57 | $-0.46 | ||
| Q1 25 | $1.55 | $-0.50 | ||
| Q4 24 | $1.37 | $-0.09 | ||
| Q3 24 | $0.74 | $-0.09 | ||
| Q2 24 | $0.96 | $-0.08 | ||
| Q1 24 | $0.93 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.9M |
| Total DebtLower is stronger | $188.2M | — |
| Stockholders' EquityBook value | $650.9M | $327.2M |
| Total Assets | $5.8B | $488.9M |
| Debt / EquityLower = less leverage | 0.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.9M | ||
| Q3 25 | — | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | — | $102.3M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $103.0M | ||
| Q1 24 | — | $125.2M |
| Q4 25 | $188.2M | — | ||
| Q3 25 | $170.5M | — | ||
| Q2 25 | $122.7M | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $28.1M | — | ||
| Q3 24 | $30.5M | — | ||
| Q2 24 | $108.6M | — | ||
| Q1 24 | $58.6M | — |
| Q4 25 | $650.9M | $327.2M | ||
| Q3 25 | $622.2M | $466.0M | ||
| Q2 25 | $587.7M | $486.3M | ||
| Q1 25 | $571.9M | $511.4M | ||
| Q4 24 | $549.0M | $538.5M | ||
| Q3 24 | $566.0M | $541.2M | ||
| Q2 24 | $530.7M | $542.5M | ||
| Q1 24 | $520.8M | $544.0M |
| Q4 25 | $5.8B | $488.9M | ||
| Q3 25 | $5.7B | $601.1M | ||
| Q2 25 | $5.6B | $624.7M | ||
| Q1 25 | $5.5B | $631.9M | ||
| Q4 24 | $5.6B | $656.2M | ||
| Q3 24 | $5.5B | $645.1M | ||
| Q2 24 | $4.9B | $651.4M | ||
| Q1 24 | $4.9B | $652.7M |
| Q4 25 | 0.29× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.21× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $90.4M | $-29.4M |
| Free Cash FlowOCF − Capex | $86.4M | $-29.5M |
| FCF MarginFCF / Revenue | 122.5% | -51.6% |
| Capex IntensityCapex / Revenue | 5.6% | 0.2% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $144.3M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.4M | $-29.4M | ||
| Q3 25 | $26.9M | $-31.6M | ||
| Q2 25 | $12.7M | $-15.3M | ||
| Q1 25 | $21.1M | $-33.1M | ||
| Q4 24 | $60.4M | $-1.8M | ||
| Q3 24 | $23.3M | $-14.6M | ||
| Q2 24 | $8.8M | $-6.9M | ||
| Q1 24 | $12.4M | $7.6M |
| Q4 25 | $86.4M | $-29.5M | ||
| Q3 25 | $25.8M | $-31.8M | ||
| Q2 25 | $11.6M | $-15.6M | ||
| Q1 25 | $20.5M | $-33.6M | ||
| Q4 24 | $54.3M | $-2.0M | ||
| Q3 24 | $19.5M | $-14.7M | ||
| Q2 24 | $8.4M | $-7.0M | ||
| Q1 24 | $11.5M | $7.6M |
| Q4 25 | 122.5% | -51.6% | ||
| Q3 25 | 39.2% | -56.5% | ||
| Q2 25 | 18.4% | -29.6% | ||
| Q1 25 | 32.8% | -67.1% | ||
| Q4 24 | 87.8% | -3.8% | ||
| Q3 24 | 33.5% | -30.9% | ||
| Q2 24 | 17.2% | -13.9% | ||
| Q1 24 | 23.7% | 15.9% |
| Q4 25 | 5.6% | 0.2% | ||
| Q3 25 | 1.7% | 0.3% | ||
| Q2 25 | 1.8% | 0.6% | ||
| Q1 25 | 0.9% | 0.9% | ||
| Q4 24 | 9.9% | 0.4% | ||
| Q3 24 | 6.5% | 0.3% | ||
| Q2 24 | 0.7% | 0.2% | ||
| Q1 24 | 2.0% | 0.0% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | 0.68× | — | ||
| Q1 25 | 1.14× | — | ||
| Q4 24 | 3.72× | — | ||
| Q3 24 | 2.67× | — | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.14× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
THFF
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
